The UAE MRI Market was valued at $33.20 Mn in 2023 and is predicted to grow at a CAGR of 7.50% from 2023 to 2030, to $55.08 Mn by 2030. The key drivers of this industry include increasing prevalence of chronic diseases, medical tourism, and increasing healthcare infrastructure. The key players in the industry are Siemens Healthineers UAE, Abu Dhabi International Medical Services, Neusoft Medical, and American Upright MRI among others.
The Egypt Radiology Service Market was valued at $11.2 Mn in 2023 and is predicted to grow at a CAGR of 16.2% from 2023 to 2030, to $32 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and growing awareness. The prominent players of the Egypt Radiology Service Market are Andalusia Al Maadi Hospital, Dar Al Fouad Hospital, As-Salam International Hospital, Andalusia Al Shalalat Hospital, and Arab Contractors Medical Center (ACMC), among others.
The Philippines Biobanks Market was valued at $168.83 Mn in 2023 and is predicted to grow at a CAGR of 9.30% from 2023 to 2030, to $314.62 Mn by 2030. The key drivers of this industry include rising health challenges, growing demand for precision medicine, and technological advancements. The industry is primarily dominated by players such as Merck KGaA, Thermo Fisher Scientific, QIAGEN, and Avantor among others.
Indonesia Chronic Cough Therapeutics Market was valued at $38 Mn in 2022 and is estimated to reach $70 Mn in 2030, exhibiting a CAGR of 8.1% during the forecast period. The key driver behind the growth of the chronic cough therapeutics market is the prevalent occurrence of chronic respiratory infections, often identified by persistent coughing. Leading participants in this market presently include Kalbe Farma, Sanofi, Bristol-Myers Squibb, PT Merck Sharp & Dohme, PT Pfizer, AstraZeneca, Boehringer Ingelheim, Chiesi, Novartis and GlaxoSmithKline.
The Saudi Arabia MRI Market was valued at $112.88 Mn in 2023 and is predicted to grow at a CAGR of 8% from 2023 to 2030, to $193.46 Mn by 2030. The key drivers of this industry include rising prevalence of chronic diseases, technological advancements in MRI, and aging population. The key players in the industry are GE Healthcare, Esaote, Siemens Healthineers, and Koninklijke Philips N.V. among others.
The Kenya Radiology Service Market was valued at $2.8 Mn in 2023 and is predicted to grow at a CAGR of 15.8% from 2023 to 2030, to $7.8 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and growing awareness. The prominent players of the Kenya Radiology Service Market are Aga Khan University Hospital, Nairobi Hospital, Kenyatta National Hospital, Mater Misericordiae Hospital, and M.P. Shah Hospital, among others.
The Mexico Biobanks Market was valued at $1,151.10 Mn in 2023 and is predicted to grow at a CAGR of 9.05% from 2023 to 2030, to $2,111.02 Mn by 2030. The key drivers of this industry include the prevalence of diseases, advancements in genomic research, and government and institutional support. The industry is primarily dominated by players such as Merck KGaA, Thermo Fisher Scientific, QIAGEN, and Avantor among others.
The US MRI Market was valued at $2788.80 Mn in 2023 and is predicted to grow at a CAGR of 4.5% from 2023 to 2030, to $3795.17 Mn by 2030. The key drivers of this industry include like increasing prevalence of chronic diseases, advancements in MRI, and medical tourism. The key players in the industry are Siemens Healthineers, Esaote North America, Rayus Radiology, and Fonar Corporation among others.
The South Africa Radiology Service Market was valued at $26 Mn in 2023 and is predicted to grow at a CAGR of 15.93% from 2023 to 2030, to $73.2 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and growing awareness. The prominent players of the South Africa Radiology Service Market are Midlands Medical Centre (MMC) Private Hospital, Chris Hani Baragwanath Hospital, Cormed Hospital, Life Rosepark Hospital, Mediclinic Hoogland Hospital, and Busamed Lowveld Private Hospital, among others.
The Kenya Biobanks Market was valued at $53.72 Mn in 2023 and is predicted to grow at a CAGR of 9.90% from 2023 to 2030, to $104.02 Mn by 2030. The key drivers of this industry include disease burden, increasing biomedical research activities, and the growth of personalized medicine. The industry is primarily dominated by players such as Merck KGaA, QIAGEN, Tecan Group, and Becton, Dickinson and Company among others.
Japan Chronic Cough Therapeutics Market was valued at $392 Mn in 2022 and is estimated to reach $758 Mn in 2030, exhibiting a CAGR of 8.6% during the forecast period. The key driver behind the growth of the chronic cough therapeutics market is the prevalent occurrence of chronic respiratory infections, often identified by persistent coughing. Leading participants in this market presently include Eisai Co., Taisho Pharmaceutical Co., Shionogi & Co., Daiichi Sankyo Co., Sumitomo Dainippon Pharma Co., AstraZeneca, Boehringer Ingelheim, Chiesi, Novartis and GlaxoSmithKline.
The Brazil MRI Market was valued at $166 Mn in 2023 and is predicted to grow at a CAGR of 7.5% from 2023 to 2030, to $275.40 Mn by 2030. The key drivers of this industry include increasing prevalence of chronic diseases, rising healthcare investment, and growing demand for accurate diagnosis. The key players in the industry are Koninklijke Philips NV, Neusoft, Esaote, and GE Healthcare among others.
The India Radiology Service Market was valued at $72.7 Mn in 2023 and is predicted to grow at a CAGR of 17.7% from 2023 to 2030, to $277.6 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and technological advancements. The prominent players of the India Radiology Service Market are Gleneagles Global Hospital, BLK Super Specialty Hospital, Apollo Hospitals, Tata Memorial Hospital, and Fortis Hospital, among others.
The Canada Hypersomnia Therapeutics Market was valued at $184.00 Mn in 2023 and is predicted to grow at a CAGR of 4.5% from 2023 to 2030, to $250.40 Mn by 2030. The key drivers of this industry include the rising prevalence of sleep disorders, expanding geriatric population, early detection, and advancement in diagnostic tools. The key players in the industry are Jazz Pharmaceuticals, Teva, Takeda, and Avadel Pharmaceuticals among others.
Kenya Chronic Cough Therapeutics Market was valued at $4 Mn in 2022 and is estimated to reach $9 Mn in 2030, exhibiting a CAGR of 9.2% during the forecast period. The primary catalyst propelling the expansion of the chronic cough therapeutics market is the widespread prevalence of persistent coughing linked to chronic respiratory infections. Key players in this industry comprise Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis, Sanofi, Merck & Co., AstraZeneca, Abbott Laboratories, Bayer AG, and Chiesi Farmaceutici.
The Mexico MRI Market was valued at $99.60 Mn in 2023 and is predicted to grow at a CAGR of 6.75% from 2023 to 2030, to $157.34 Mn by 2030. The key drivers of this industry include increasing prevalence of chronic diseases, medical tourism, and supportive government initiatives. The key players in the industry are Siemens Healthineers, Esaote, K.A. Imaging, and Fonar Corporation among others.
Kenya Hemodialysis Vascular Grafts Market was valued at $150 Mn in 2023 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $220 Mn by 2030. The key drivers of this industry include factors like the rising prevalence of chronic kidney disease, limited kidney transplant options, and growing awareness and improved diagnosis. The industry is primarily dominated by W. L. Gore, C. R. Bard, Vascudyne, and LeMaitre among others
The US Hypersomnia Therapeutics Market was valued at $966 Mn in 2023 and is predicted to grow at a CAGR of 2.50% from 2023 to 2030, to $1,148.27 Mn by 2030. The key drivers of this industry include increasing awareness, lifestyle changes, expanding geriatric population, and early detection. The key players in the industry are Pfizer, Johnson & Johnson, Merck, GSK, and Sanofi among others.
Malaysia Chronic Cough Therapeutics Market was valued at $10 Mn in 2022 and is estimated to reach $19 Mn in 2030, exhibiting a CAGR of 8.3% during the forecast period. The primary factor fuelling the expansion of the chronic cough therapeutics market is the widespread prevalence of chronic respiratory infections, frequently characterized by persistent coughing. Key players in this industry at present comprise Pfizer, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, AstraZeneca, Boehringer Ingelheim, Teva Pharmaceuticals, Hikma Pharmaceuticals, and Abbott Laboratories.
The France MRI Market was valued at $182.60 Mn in 2023 and is predicted to grow at a CAGR of 5.5% from 2023 to 2030, to $265.62 Mn by 2030. The key drivers of this industry include rising prevalence of chronic diseases, technological advancements, and increasing government expenditure. The key players in the industry are Siemens Healthineers, GE Healthcare, Hitachi Medical Corporation, and Hologic among others.
Singapore Hemodialysis Vascular Grafts Market was valued at $250 Mn in 2023 and is predicted to grow at a CAGR of 5.7% from 2023 to 2030, to $370 Mn by 2030. The key drivers of this industry include the rising prevalence of end-stage renal disease, high healthcare expenditure, and focus on quality care. The industry is primarily dominated by W. L. Gore, C. R. Bard, Vascudyne, and LeMaitre among others.
The Saudi Arabia Hypersomnia Therapeutics Market was valued at $184.89 Mn in 2023 and is predicted to grow at a CAGR of 6.0% from 2023 to 2030, to $278.01 Mn by 2030. The key drivers of this industry include the rising prevalence of sleep disorders, expanding geriatric population, early detection, and advancement in diagnostic tools. The key players in the industry are Pfizer, Sanofi, Teva, GSK, and Novartis among others.
Philippines Chronic Cough Therapeutics Market was valued at $14 Mn in 2022 and is estimated to reach $27 Mn in 2030, exhibiting a CAGR of 8.6% during the forecast period. The primary factor fuelling the expansion of the chronic cough therapeutics market is the widespread prevalence of chronic respiratory infections, frequently characterized by persistent coughing. Key players in this industry at present comprise Pfizer, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, AstraZeneca, Boehringer Ingelheim, Teva Pharmaceuticals, Hikma Pharmaceuticals, and Abbott Laboratories.
The Germany MRI Market was valued at $243.02 Mn in 2023 and is predicted to grow at a CAGR of 4.7% from 2023 to 2030, to $335.18 Mn by 2030. The key drivers of this industry include the high prevalence of cardiovascular diseases, technological advancements in MRI, and increased healthcare expenditure. The key players in the industry are Siemens Healthineers, Hitachi Medical Systems, Hologic Inc., and SternMed GmbH among others.
Vietnam Hemodialysis Vascular Grafts Market was valued at $1,050 Mn in 2023 and is predicted to grow at a CAGR of 5.33% from 2023 to 2030, to $1,510 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic kidney disease, the aging population, and technological advancements. The industry is primarily dominated by W. L. Gore, C. R. Bard, Vascudyne, and LeMaitre among others.